close
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Jan-Feb;60(1):38-48.

Biliverdin reductase: new features of an old enzyme and its potential therapeutic significance

Urszula M Florczyk  1 , Alicja Jozkowicz, Jozef Dulak
Affiliations
Review

Biliverdin reductase: new features of an old enzyme and its potential therapeutic significance

Urszula M Florczyk et al. Pharmacol Rep. 2008 Jan-Feb.

Abstract

Biliverdin reductase (BVR) was known for a long time solely as an enzyme converting biliverdin to bilirubin, the major physiological antioxidant. Recent years revealed unique features of this protein which are not related to its reductase activity. The most intriguing and surprising finding is its dual-specificity kinase character. As such serine/threonine/tyrosine kinase BVR is involved in regulation of glucose metabolism or in control of cell growth and apoptosis. In consequence, it may play a role in pathogenesis of many diseases, such as diabetes or cancers. Moreover, in the nucleus BVR, being a leucine zipper-like DNA binding protein, can act as a transcription factor for activator protein 1 (AP-1)-regulated genes. It has been shown that BVR modulates ATF-2 and HO-1 expression, what suggests its potential role in control of AP-1 and cAMP-regulated genes. In conclusion, BVR together with its substrate, biliverdin, and product, bilirubin, are revealed to be important players in cellular signal transduction pathways, gene expression and oxidative response. These features make BVR unusually interesting and unique among all enzymes characterized to date.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Heme degradation by heme oxygenase system. α-Meso carbon bridge of the heme molecule is broken by heme oxygenase, forming biliverdin and liberating CO and iron. Biliverdin is further reduced to bilirubin by biliverdin reductase
Fig. 2
Fig. 2
Rat BVR-NADH enzyme-cofactor complex. Stereoview ribbon diagram (adapted from Protein Database). The chain termini are indicated by N and C. NADH is depicted as a ball-and-stick model
Fig. 3
Fig. 3
The major activities of biliverdin reductase
See this image and copyright information in PMC

References

    1. Agarwal A, Nick HS. Renal response to tissue injury: lessons from heme oxygenase-1 gene ablation and expression. J Am Soc Nephrol. 2000;11:965–973. - PubMed
    1. Agarwal A, Shiraishi F, Visner GA, Nick HS. Linoleyl hydroperoxide transcriptionally upregulates heme oxygenase-1 gene expression in human renal epithelial and aortic endothelial cells. J Am Soc Nephrol. 1998;9:1990–1997. - PubMed
    1. Ahmad Z, Salim M, Maines MD. Human biliverdin reductase is a leucine zipper-like DNA-binding protein and functions in transcriptional activation of heme oxygenase-1 by oxidative stress. J Biol Chem. 2002;277:9226–9232. - PubMed
    1. Alam J, Shibahara S, Smith A. Transcriptional activation of the heme oxygenase gene by heme and cadmium in mouse hepatoma cells. J Biol Chem. 1989;264:6371–6375. - PubMed
    1. Alam J, Zhining D. Distal AP-1 binding sites mediate basal level enhancement and TPA induction of the mouse heme oxygenase-1 gene. J Biol Chem. 1992;267:21894–21900. - PubMed

Publication types

MeSH terms